
Rep. Glenn Grothman @RepGrothman
In September, I introduced a bill that would waive interchangeability requirements for biosimilar insulins. This means more competition in the market, lower costs and increased options for patients. https://t.co/7EsF3j3kPe — PolitiTweet.org